GC Corp. (KRX:005257)

Market Cap	634.72B -3.0%
Revenue (ttm)	2.40T +9.9%
Net Income	127.58B
EPS	2,832.40
Shares Out	n/a
PE Ratio	4.98
Forward PE	n/a
Dividend	300.00 (1.35%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,314
Open	22,800
Previous Close	22,150
Day's Range	22,000 - 22,800
52-Week Range	22,000 - 73,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About GC Corp.

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; a...

• Industry: Pharmaceutical Preparations
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005257